Lamassu Biotech
Phase 1/2A Patient-Centric Approach Leveraging Novel and Targeted Strategies With High Potential for Clinical Success
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
A Patient-Centric Approach Leveraging Novel and Targeted Strategies With High Potential for Clinical Success
Small Molecules